SAN FRANCISCO, Nov. 5 – Applied Gene Technologies has entered a development, manufacturing, and marketing deal with Taiwanese biopharmaceutical company AsiaGen, the companies announced Monday.

Applied Gene Technologies, based in San Diego, will develop tuberculosis diagnostics using its Tessera Array Technology for AsiaGen, which received exclusive rights to manufacture and market the product in Asia.

Applied Gene Technologies will receive an upfront payment for the development work, according to the company. Details of the payment were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.